Why is the SARS-CoV-2 Omicron variant milder?

Bingqing Xia; Yi Wang; Xiaoyan Pan; Xi Cheng; Hongying Ji; Xiaoli Zuo; Hualiang Jiang; Jia Li; Zhaobing Gao

doi:10.1016/j.xinn.2022.100251

Why is the SARS-CoV-2 Omicron variant milder?

Innovation (Camb). 2022 Jul 12;3(4):100251. doi: 10.1016/j.xinn.2022.100251. Epub 2022 Apr 26.

Authors

Bingqing Xia^{1

2}, Yi Wang^{1

3}, Xiaoyan Pan⁴, Xi Cheng^{1

2}, Hongying Ji¹, Xiaoli Zuo¹, Hualiang Jiang^{1

2

5}, Jia Li^{1

2}, Zhaobing Gao^{1

2}

Affiliations

¹ CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
² University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
³ State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Fudan University, Shanghai 200032, China.
⁴ State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
⁵ Lingang Laboratory, Shanghai 201602, China.

No abstract available

Publication types

News